Jae Shin is an Infectious Disease physician affiliated with Hoag Memorial Hospital Presbyterian. OpenAlex indexes 78 publications with 1,131 citations (h-index 16); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
320 Superior Ave Ste 370
Newport Beach, CA 926632795
Telephone
949-515-3590Provider last certified this registry record 11 Sept 2025.
Clinical trials
- Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
Sponsor: Pusan National University Hospital
- Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy
Sponsor: Pusan National University Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year202515 payments
- Gilead Sciences, Inc.Program year20259 payments
- Paratek Pharmaceuticals, Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Cephalosporin Antibacterial28.4%Ceftriaxone62%Cefepime Hcl38%Part D<11 patientsOther antibacterials19.6%Methenamine Hippurate100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Factors associated with failure of fecal microbiota transplant for recurrent <i>Clostridioides difficile</i> infection
Therapeutic Advances in Gastroenterology
2025 - ApoE COG 133 mimetic peptide improves survival, infection burden, and Clostridioides difficile toxin-A-induced intestinal damage in mice
Experimental Biology and Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Rajesh Banker, MD
Hoag Memorial Hospital Presbyterian
Michael Brant-Zawadzki, MD
Hoag Memorial Hospital Presbyterian
Alain Mita, MD
Hoag Memorial Hospital Presbyterian
William Shankle, MS, MD
Hoag Memorial Hospital Presbyterian
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”